1 Patients in this subgroup had the highest
five-year survival rate.
2 confidence interval, 0.60 to 0.93; P=0.009;
five-year survival rate,
36 percent vs. 23 percent) and
3 The expected
five-year survival rate (
79 percent) was identical to th
4 One-year and
five-year survival rates after transplantation among pat
5 The
five-year survival rate among patients whose cancer had
6 Five-year survival rates approach 70% with surgical rese
7 Five-year survival rates are lowest for AYA women, and o
8 Five-year survival rates for breast cancer as influenced
9 Although
five-year survival rates for childhood acute lymphoblast
10 Five-year survival rates for childhood cancer have impro
11 Five-year survival rates for early stage colorectal, bre
12 Five-year survival rates for patients with tumors less t
13 Five-year survival rates for resected intrahepatic, peri
14 Five-year survival rates for TM + and TM- were 21% and 7
15 Five-year survival rates have increased in the recent pa
16 Finally, we compared
five-year survival rates in blacks and whites.
17 Five-year survival rates increased from 83.7% in 1990-19
18 Five-year survival rate of stage IV patient with all of
19 he chemotherapy resulted in overall two- and
five-year survival rates of 44 percent and 23 percent, a
20 Five-year survival rates of patients with VWF:Ag < 110,
21 The prognosis is poor and the
five-year survival rate ranges from 20% (OSCC in the flo
22 regurgitant orifice of at least 40 mm2 had a
five-year survival rate that was lower than expected on
23 Five-year survival rates typically range from 89% to 96%
24 e II disease whose tumors expressed DCC, the
five-year survival rate was 94.3 percent, whereas in pat
25 percent vs. 76.7 percent, P<0.001), and the
five-year survival rate was also lower for blacks (26.4
26 Five-year survival rates were 86.5%, 83.8%, and 80.1% fo
27 Five-year survival rates were above 90% for patients wit